Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Serina Therapeutics (SER) Treasury Shares (2019 - 2022)

Serina Therapeutics' Treasury Shares history spans 4 years, with the latest figure at $3000.0 for Q4 2022.

  • For Q4 2022, Treasury Shares fell 81.25% year-over-year to $3000.0; the TTM value through Dec 2022 reached $3000.0, down 81.25%, while the annual FY2022 figure was $3000.0, 81.25% down from the prior year.
  • Treasury Shares for Q4 2022 was $3000.0 at Serina Therapeutics, down from $6000.0 in the prior quarter.
  • Across five years, Treasury Shares topped out at $50000.0 in Q4 2019 and bottomed at $3000.0 in Q4 2022.
  • The 4-year median for Treasury Shares is $19000.0 (2021), against an average of $20181.8.
  • The largest annual shift saw Treasury Shares tumbled 38.71% in 2021 before it tumbled 81.25% in 2022.
  • A 4-year view of Treasury Shares shows it stood at $50000.0 in 2019, then tumbled by 44.0% to $28000.0 in 2020, then crashed by 42.86% to $16000.0 in 2021, then crashed by 81.25% to $3000.0 in 2022.
  • Per Business Quant, the three most recent readings for SER's Treasury Shares are $3000.0 (Q4 2022), $6000.0 (Q3 2022), and $9000.0 (Q2 2022).